More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
CBD for Athletes, Pets, and Puerto Rico Featured in Medical Marijuana, Inc. Coverage

CBD for Athletes, Pets, and Puerto Rico Featured in Medical Marijuana, Inc. Coverage

by adminAdrianRamirez | Feb 2, 2018 | Media Coverage

Medical Marijuana, Inc. makes headlines this week with its line of CBD oil products. The Medical Marijuana, Inc. portfolio of companies was featured in a number of news outlets this week as it promotes its lines of CBD oil products to markets around the world,...
Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First-Ever Brand Ambassadors to Achieve Crown Ambassador Elite Rank

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First-Ever Brand Ambassadors to Achieve Crown Ambassador Elite Rank

by adminAdrianRamirez | Feb 2, 2018 | Kannaway, Press Releases

SAN DIEGO, Feb. 2, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing its first-ever pair of Brand...
Medical Marijuana, Inc. Subsidiary HempMeds® Garners National Media Coverage on TMZ Entertainment News

Medical Marijuana, Inc. Subsidiary HempMeds® Garners National Media Coverage on TMZ Entertainment News

by adminAdrianRamirez | Feb 1, 2018 | HempMeds, Press Releases

SAN DIEGO, Feb. 1, 2018 /PRNewswire/ — Medical Marijuana, Inc.(OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® garnered national news coverage on prominent entertainment news website TMZ....
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Names Ian Quinn as CEO

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Names Ian Quinn as CEO

by adminAdrianRamirez | Jan 31, 2018 | Press Releases

Veteran Advocate and Humanitarian Leads Charge in Hemp-Based Cannabidiol (CBD) Products for Animals SAN DIEGO, Jan. 31, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced Ian Quinn as...
Medical Marijuana, Inc. Named a Top 3 Hemp Producer of 2018

Medical Marijuana, Inc. Named a Top 3 Hemp Producer of 2018

by adminAdrianRamirez | Jan 30, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Jan. 30, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that it has been named one of three top hemp producers of 2018 by MMJ Reporter. According to a report by the Hemp...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.